Clinical Trial Update: Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab [Phase 2]

View source ↗

Summary

Phase 2 trial in older patients with B-cell precursor acute lymphoblastic leukemia evaluating sequential dose-reduced chemotherapy followed by blinatumomab; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Goethe University | Conditions: B-Precursor ALL | Phase 2 | Status: COMPLETED